Variant report
Variant | esv3402547 |
---|---|
Chromosome Location | chr2:179181256-179183354 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr2:179181197-179181327 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | MXI1 | chr2:179182804-179182811 | GM12878 | blood: | n/a | n/a |
3 | MXI1 | chr2:179181709-179181750 | K562 | blood: | n/a | n/a |
4 | POLR2A | chr2:179182878-179182959 | ProgFib | skin: | n/a | n/a |
5 | RFX5 | chr2:179181802-179181826 | K562 | blood: | n/a | n/a |
6 | RFX5 | chr2:179181341-179181376 | K562 | blood: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:179175553..179178378-chr2:179180184..179181905,2 | K562 | blood: | |
2 | chr2:179174805..179177159-chr2:179180996..179182677,2 | MCF-7 | breast: | |
3 | chr2:179182101..179184343-chr2:179194524..179196984,2 | K562 | blood: | |
4 | chr2:179173279..179175264-chr2:179179066..179181987,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OSBPL6 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4894007 | chr2:179181257-179181258 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs547176960 | chr2:179181283-179181284 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs565601323 | chr2:179181308-179181309 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs534405406 | chr2:179181313-179181314 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs201332508 | chr2:179181320-179181321 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs557479909 | chr2:179181328-179181329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190584287 | chr2:179181346-179181347 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs182237826 | chr2:179181349-179181350 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs556941563 | chr2:179181350-179181351 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs4893851 | chr2:179181425-179181426 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs542417126 | chr2:179181433-179181434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs370242471 | chr2:179181440-179181441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572999865 | chr2:179181443-179181444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545495183 | chr2:179181450-179181451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs370412589 | chr2:179181457-179181458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184329055 | chr2:179181464-179181465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189089614 | chr2:179181588-179181589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7573288 | chr2:179181600-179181601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372611623 | chr2:179181608-179181609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4894008 | chr2:179181622-179181623 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs576504186 | chr2:179181741-179181742 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs34971056 | chr2:179181785-179181786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181571678 | chr2:179181806-179181807 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs547022701 | chr2:179181863-179181864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560735327 | chr2:179182005-179182006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185270095 | chr2:179182023-179182024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4894009 | chr2:179182109-179182110 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs571027026 | chr2:179182110-179182111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200443448 | chr2:179182165-179182166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs58865067 | chr2:179182192-179182193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs60762666 | chr2:179182196-179182197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs57163886 | chr2:179182202-179182203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552681762 | chr2:179182209-179182210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200253955 | chr2:179182214-179182215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536622066 | chr2:179182363-179182364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550554403 | chr2:179182369-179182370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567190939 | chr2:179182450-179182451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543275382 | chr2:179182494-179182495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532418702 | chr2:179182544-179182545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553019389 | chr2:179182557-179182558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541307602 | chr2:179182587-179182588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs993598 | chr2:179182695-179182696 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs368491931 | chr2:179182707-179182708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs13398164 | chr2:179182733-179182734 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs191260503 | chr2:179182794-179182795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544579341 | chr2:179182849-179182850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530336526 | chr2:179182931-179182932 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs180738062 | chr2:179182933-179182934 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs186088150 | chr2:179182945-179182946 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs574787771 | chr2:179182954-179182955 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Mental retardation | 21062444 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Schizophrenia | 19348701 | CNVD |
Muscular dystrophy | 17160897 | CNVD |
Cardiomyopathy | 17576883 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Breast cancer | 22522925 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Autism | 20531469 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:179143200-179188600 | Weak transcription | Brain Anterior Caudate | brain |
2 | chr2:179160200-179188600 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
3 | chr2:179164600-179200800 | Weak transcription | Aorta | Aorta |
4 | chr2:179171600-179182000 | Weak transcription | HSMM | muscle |
5 | chr2:179176200-179198000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
6 | chr2:179176400-179183400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr2:179180400-179183200 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
8 | chr2:179180600-179183400 | Weak transcription | Psoas Muscle | Psoas |
9 | chr2:179180600-179183600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
10 | chr2:179180600-179184000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
11 | chr2:179180800-179182800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
12 | chr2:179180800-179184400 | Weak transcription | Liver | Liver |
13 | chr2:179181000-179188600 | Weak transcription | K562 | blood |
14 | chr2:179182400-179184800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
15 | chr2:179182400-179185400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr2:179182600-179183800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
17 | chr2:179182800-179183400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
18 | chr2:179182800-179183600 | Enhancers | Primary hematopoietic stem cells | blood |
19 | chr2:179183200-179183800 | Enhancers | Skeletal Muscle Female | skeletal muscle |